Analysis of gastrointestinal and hepatic chronic grant-versus-host disease manifestations on major outcomes: A chronic grant-versus-host disease consortium study

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 5, 2013, Pages 784-791

  Pidala, Joseph ^a   Chai, Xiaoyu ^b   Kurland, Brenda F ^b   Inamoto, Yoshihiro ^b   Flowers, Mary E D ^b   Palmer, Jeanne ^c   Khera, Nandita ^d   Jagasia, Madan ^e   Cutler, Corey ^f   Arora, Mukta ^g   Vogelsang, Georgia ^h   Lee, Stephanie J ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d MAYO CLINIC   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Chronic GVHD; Gastrointestinal; Hepatic

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILIRUBIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; COHORT ANALYSIS; ESOPHAGUS; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PRESCHOOL CHILD; PROGNOSIS; QUALITY OF LIFE; SCHOOL CHILD; UPPER GASTROINTESTINAL TRACT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COHORT STUDIES; FEMALE; GASTROINTESTINAL TRACT; GRAFT VS HOST DISEASE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; PROGNOSIS; YOUNG ADULT;

EID: 84876335897     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.02.001     Document Type: Article

References (33)

1. Arai S., Jagasia M., Storer B., et al. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. Blood 2011, 118:4242-4249.
2. Fraser C.J., Bhatia S., Ness K., et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood 2006, 108:2867-2873.
3. Lee S.J., Flowers M.E. Recognizing and managing chronic graft-versus-host disease. Hematology Am Soc Hematol Educ Program 2008, 134-141.
4. Lee S.J., Vogelsang G., Flowers M.E. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003, 9:215-233.
5. Pidala J., Anasetti C., Jim H. Quality of life after allogeneic hematopoietic cell transplantation. Blood 2009, 114:7-19.
6. Pidala J., Anasetti C., Jim H. Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention. Br J Haematol 2010, 148:373-385.
7. Pidala J., Kim J., Anasetti C., et al. The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality. Haematologica 2011, 96:1678-1684.
8. Pidala J., Kurland B., Chai X., et al. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. Blood 2011, 117:4651-4657.
9. Pidala J., Kurland B., Chai X., et al. Sensitivity of changes in chronic graft vs. host disease activity (measured by National Institute of Health global severity, clinician, and patient assessment) to changes in patient-reported quality of life: results from the chronic graft vs. host disease Consortium. Haematologica 2011, 96:1528-1535.
10. Stewart B.L., Storer B., Storek J., et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 2004, 104:3501-3506.
11. Arora M., Nagaraj S., Witte J., et al. New classification of chronic GVHD: added clarity from the consensus diagnoses. Bone Marrow Transplant 2009, 43:149-153.
12. Jagasia M., Giglia J., Chinratanalab W., et al. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Biol Blood Marrow Transplant 2007, 13:1207-1215.
13. Cho B.S., Min C.K., Eom K.S., et al. Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia 2009, 23:78-84.
14. Vigorito A.C., Campregher P.V., Storer B.E., et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 2009, 114:702-708.
15. Pidala J., Vogelsang G., Martin P., et al. Overlap subtype of chronic graft vs. host disease is associated with adverse prognosis, functional impairment, and inferior patient reported outcomes: a chronic graft vs. host disease Consortium study. Haematologica 2012, 97:451-458.
16. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
17. Chronic GVHD Consortium Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD. Biol Blood Marrow Transplant 2011, 17:1114-1120.
18. Mathiowetz V., Weber K., Volland G., Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg Am 1984, 9:222-226.
19. Pavletic S.Z., Martin P., Lee S.J., et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 2006, 12:252-266.
20. Waters R.L., Lunsford B.R., Perry J., Byrd R. Energy-speed relationship of walking: standard tables. J Orthop Res 1988, 6:215-222.
21. Li L., Chan L., Gerber L.H. Validation of 2-minute walk test as a measure of exercise tolerance and physical performance in patients with chronic graft versus host disease. Arch Phys Med and Rehabil 2008, 89:e28.
22. Lee S., Cook E.F., Soiffer R., Antin J.H. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2002, 8:444-452.
23. Daughton D.M., Fix A.J., Kass I., et al. Maximum oxygen consumption and the ADAPT quality-of-life scale. Arch Phys Med Rehabil 1982, 63:620-622.
24. Herzberg P.Y., Heussner P., Mumm F.H., et al. Validation of the Human Activity Profile Questionnaire in patients after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010, 16:1707-1717.
25. McQuellon R.P., Russell G.B., Cella D.F., et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplantation 1997, 19:357-368.
26. Fehse N., Fehse B., Kroger N., et al. Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantation. J Hematother Stem Cell Res 2003, 12:237-242.
27. McHorney C.A., Ware J.E., Raczek A.E. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care 1993, 31:247-263.
28. Ware J.E., Kosinski M., Keller S.D. SF-36 Physical and Mental Health Summary Scales: A User's Manual 1994, The Health Institute, Boston.
29. Ware J.E., Snow K.K., Kosinski M., Gandek B. SF-36 Health Survey: Manual and Interpretation Guide 1993, The Health Institute, Boston.
30. Ware J.E., Kosinski M., Dewey J. How to Score Version 2 of the SF-36ò Health Survey 2000, QualityMetric Incorporated, Lincoln, RI.
31. Feinstein L.C., Sandmaier B.M., Hegenbart U., et al. Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission. Br J Haematol 2003, 120:281-288.
32. Arora M., Klein J.P., Weisdorf D.J., et al. Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis. Blood 2011, 117:6714-6720.
33. Wingard J.R., Piantadosi S., Vogelsang G.B., et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood 1989, 74:1428-1435.